CN110257412B - 一种新颖的细胞系筛选方法 - Google Patents

一种新颖的细胞系筛选方法 Download PDF

Info

Publication number
CN110257412B
CN110257412B CN201910335307.XA CN201910335307A CN110257412B CN 110257412 B CN110257412 B CN 110257412B CN 201910335307 A CN201910335307 A CN 201910335307A CN 110257412 B CN110257412 B CN 110257412B
Authority
CN
China
Prior art keywords
reporter gene
dna
cell
protein
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201910335307.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN110257412A (zh
Inventor
余波
詹姆斯·拉里克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LARIX BIOSCIENCES LLC
Original Assignee
LARIX BIOSCIENCES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LARIX BIOSCIENCES LLC filed Critical LARIX BIOSCIENCES LLC
Priority to CN201910335307.XA priority Critical patent/CN110257412B/zh
Publication of CN110257412A publication Critical patent/CN110257412A/zh
Application granted granted Critical
Publication of CN110257412B publication Critical patent/CN110257412B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201910335307.XA 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法 Expired - Fee Related CN110257412B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910335307.XA CN110257412B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261732156P 2012-11-30 2012-11-30
US61/732,156 2012-11-30
PCT/US2013/072412 WO2014085711A1 (en) 2012-11-30 2013-11-27 A novel cell line screening method
CN201910335307.XA CN110257412B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法
CN201380062665.9A CN104870646B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380062665.9A Division CN104870646B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法

Publications (2)

Publication Number Publication Date
CN110257412A CN110257412A (zh) 2019-09-20
CN110257412B true CN110257412B (zh) 2023-12-15

Family

ID=49880972

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201910335307.XA Expired - Fee Related CN110257412B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法
CN201380062665.9A Active CN104870646B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201380062665.9A Active CN104870646B (zh) 2012-11-30 2013-11-27 一种新颖的细胞系筛选方法

Country Status (5)

Country Link
US (2) US9910038B2 (enExample)
EP (2) EP3382026B1 (enExample)
JP (2) JP6442411B2 (enExample)
CN (2) CN110257412B (enExample)
WO (1) WO2014085711A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3382026B1 (en) * 2012-11-30 2021-01-06 Larix Biosciences LLC A novel cell line screening method
WO2016132122A1 (en) * 2015-02-17 2016-08-25 University Of Edinburgh Assay construct
CN112513279B (zh) * 2018-07-09 2025-01-17 杰诺维有限公司 用于在重组酶介导的核酸序列向工程化的接受细胞发生盒交换整合期间追踪和操纵细胞的细胞表面标签交换(cste)系统
US20210356377A1 (en) * 2018-09-07 2021-11-18 Medimmune, Llc Methods Of Cell Selection
EP3990649A1 (en) * 2019-06-26 2022-05-04 Genentech, Inc. Randomized configuration targeted integration of nucleic acids
WO2025176217A1 (en) * 2024-02-22 2025-08-28 The University Of Hong Kong Conditional splicing system for tight control of viral overlapping genes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070931A2 (de) * 2002-02-21 2003-08-28 Vision 7 Gmbh Verfahren zur ortsspezifischen dna-rekombination
WO2004007686A2 (en) * 2002-07-12 2004-01-22 Emory University Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates
CN101671653A (zh) * 2009-09-22 2010-03-17 浙江大学 一种hiv侵染细胞的筛选系统及其应用
CN102762728A (zh) * 2009-11-19 2012-10-31 株式会社免疫工学研究所 用于制备产生期望的多肽的抗体生产细胞的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1293564A4 (en) * 2000-06-08 2005-08-17 Mitsubishi Pharma Corp EXPRESSION VECTOR FOR SCREENING CELLS HIGH EXPRESSION OF RECOMBINANT PROTEINS, TRANSFORMING HIGH EXPRESSION OF A RECOMBINANT PROTEIN AND USE THEREOF
US6406863B1 (en) * 2000-06-23 2002-06-18 Genetastix Corporation High throughput generation and screening of fully human antibody repertoire in yeast
US20030059763A1 (en) * 2001-01-26 2003-03-27 Andrew Saxon Immunoglobulin class switch recombination
GB0118337D0 (en) 2001-07-27 2001-09-19 Lonza Biologics Plc Method for selecting antibody expressing cells
US20040115814A1 (en) * 2002-09-30 2004-06-17 Protein Design Labs, Inc. Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
ATE440949T1 (de) * 2004-01-30 2009-09-15 Maxygen Holdings Ltd Gesteuertes überlesen von stopcodons
AU2006304387A1 (en) 2005-10-14 2007-04-26 Medimmune, Llc Cell display of antibody libraries
WO2008070367A2 (en) 2006-11-01 2008-06-12 Facet Biotech Corporation Mammalian cell-based immunoglobulin display libraries
DK2150617T3 (en) 2007-06-04 2015-01-12 Regeneron Pharma Regions with increased expression and stability
WO2009059235A2 (en) * 2007-11-01 2009-05-07 Facet Biotech Corporation Immunoglobulin display vectors
US9758779B2 (en) 2008-08-28 2017-09-12 Novartis Ag Cell surface display of polypeptide isoforms by stop codon readthrough
JP2011182645A (ja) * 2010-03-04 2011-09-22 Kyushu Univ 動物細胞ディスプレイ法およびそれを利用した完全ヒトモノクローナル抗体の体外成熟法
EP3382026B1 (en) * 2012-11-30 2021-01-06 Larix Biosciences LLC A novel cell line screening method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070931A2 (de) * 2002-02-21 2003-08-28 Vision 7 Gmbh Verfahren zur ortsspezifischen dna-rekombination
WO2004007686A2 (en) * 2002-07-12 2004-01-22 Emory University Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates
CN101671653A (zh) * 2009-09-22 2010-03-17 浙江大学 一种hiv侵染细胞的筛选系统及其应用
CN102762728A (zh) * 2009-11-19 2012-10-31 株式会社免疫工学研究所 用于制备产生期望的多肽的抗体生产细胞的方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene》;Ralph Meuwissen等;《Oncogene》;20011019;第20卷;第6551-6558页 *
《phiC31 Integrase-Mediated Site-Specific Recombination in Barley》;Eszter Kapusi等;《PLOS ONE》;20120914;第7卷(第9期);第1-13页 *

Also Published As

Publication number Publication date
JP2018201520A (ja) 2018-12-27
EP2925867B1 (en) 2018-06-27
EP3382026B1 (en) 2021-01-06
WO2014085711A1 (en) 2014-06-05
CN110257412A (zh) 2019-09-20
US9910038B2 (en) 2018-03-06
JP6785272B2 (ja) 2020-11-18
EP3382026A1 (en) 2018-10-03
JP6442411B2 (ja) 2018-12-26
US20180313834A1 (en) 2018-11-01
EP2925867A1 (en) 2015-10-07
CN104870646B (zh) 2019-05-28
CN104870646A (zh) 2015-08-26
US10816548B2 (en) 2020-10-27
JP2016506239A (ja) 2016-03-03
US20140155285A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
AU2015292406B2 (en) Anti-CD3 antibodies, activatable anti-CD3 antibodies, multispecific anti-CD3 antibodies, multispecific activatable anti-CD3 antibodies, and methods of using the same
KR101317045B1 (ko) 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
CN109311977B (zh) 人源化的抗pacap抗体及其用途
KR101459159B1 (ko) Ｏｘ-2/ｃｄ200에 대한 항체 및 이들의 용도
TWI825834B (zh) 基於艾日布林之抗體-藥物結合物及使用方法
KR102361237B1 (ko) 코일드 코일 면역글로불린 융합 단백질 및 이것의 조성물
KR102182485B1 (ko) 단백질 약물의 불활성화를 위한 항체 로커
AU2021254602A1 (en) Humanized anti-MUC1* antibodies
CN108137677B (zh) 抗pacap抗体及其用途
KR20220040483A (ko) 칼리크레인 관련 펩티다제 2 항원 결합 도메인을 포함하는 단백질 및 이의 용도
DK3075745T3 (en) Mutated interleukin-2 polypeptides
CN114106183A (zh) 抗cld18a2纳米抗体及其应用
CN111954680A (zh) IL2Rβ/共同γ链抗体
EA032828B1 (ru) Иммунотерапевтические средства против комплекса tcr
KR20230017841A (ko) Cd3 항원 결합 도메인을 포함하는 단백질 및 이의 용도
KR20220120586A (ko) 에리불린 기반의 항체-약물 컨쥬게이트의 생성 방법
CN110257412A (zh) 一种新颖的细胞系筛选方法
CN107949575A (zh) Cys80缀合型免疫球蛋白
CN114650867A (zh) 抗cd20抗体、抗cd37抗体及它们的混合物
CN114144435B (zh) 针对人trem-1的抗体及其用途
CN114174536B (zh) 抗trem-1抗体及其用途
RU2840013C1 (ru) Способ получения конъюгата антитело-лекарственное средство на основе эрибулина
HK1247628A1 (zh) 多特异性fab融合蛋白及其使用方法
HK40004152A (en) Humanized anti-pacap antibodies and uses thereof
HK40004152B (en) Humanized anti-pacap antibodies and uses thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TG01 Patent term adjustment

Free format text: NEW EXPIRY DATE: 20340720

TG01 Patent term adjustment
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20231215